Biykem Bozkurt
Michael E.DeBakey VA Medical Center, Baylor College of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Biykem Bozkurt as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:28 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT01261065 · Mechanisms of Improvement With Beta-Blocker Treatment in Heart FailureMichael E. DeBakey VA Medical Center · completed · Heart Failure, Cardiomyopathy · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:28 UTC. The ranking covers the 200 most relevant of 24 PubMed records, and a shared surname and initials can bring in a namesake. All 24 on PubMed
- Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure.Circulation · 2001326 citationsRCR 6.9
- Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.Circulation · 1999323 citationsRCR 7.2
- Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01.Ann Surg Oncol · 2018261 citationsRCR 8.2
- Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines.J Am Coll Cardiol · 2003183 citationsRCR 4.2
- Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF).J Card Fail · 2011165 citationsRCR 4.4
- Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure.Circulation · 200191 citationsRCR 2.6
- Early versus delayed laparoscopic cholecystectomy for acute cholecystitis: a prospective, randomized study.Int Surg · 201464 citationsRCR 3.7
- The effectiveness of early rehabilitation in patients with modified radical mastectomy.Cancer Nurs · 200861 citationsRCR 2.0
- Effect of atrial overdrive pacing on obstructive sleep apnea in patients with systolic heart failure.Sleep Med · 200730 citationsRCR 0.9
- Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure.J Card Fail · 200226 citationsRCR 0.5